Moolec Science Q2 2026 Earnings Results & Report

Moolec Science EPS Results

• Actual EPS: $47.4870
• Consensus EPS: N/A
• Beat/Miss: N/A
• One Year Ago EPS: N/A
• EPS Beat Rate: 1 of last 4 quarters

Moolec Science Revenue Results

• Actual Revenue: $2.62 million
• Expected Revenue: N/A
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

Moolec Science (NASDAQ:MLEC) Ltd. is a food-technology and biotechnology company developing alternative sources of animal proteins through molecular farming. The company uses genetically engineered plants, including soybeans and safflower, as biological production platforms designed to produce specific proteins that can be used in food and other applications.

Its research and development programs have included “Piggy Sooy,” a soybean engineered to produce pork protein, as well as safflower-based production of animal proteins such as chymosin, an enzyme used in cheese manufacturing. Moolec’s approach is intended to support the production of animal-derived ingredients with potentially lower resource requirements than conventional livestock-based methods.

Moolec was founded in 2020 and has developed activities connected with biotechnology and agricultural research in the United States and South America. The company is led by Chief Executive Officer Gastón Paladini, who is associated with the Paladini food group and has experience in the food industry. Moolec Science is listed on the Nasdaq under the symbol MLEC.